Drug Development China is an executive forum organized by CHI's Pharmaceutical Strategy Series where U.S. and China pharmaceutical, biotech's, and academic institutes will convene to present strategies for launching discovery and development activities.  This event will be attended by Presidents, CEOs, Managing Directors, Chief Scientific Officers, etc. seeking business collaborations. A preconference workshop will be held on September 16: "Improving China Drug Development Team Performance," lead by Dr. William Ronco, President of Gathering Pace Consulting.

(more info and registration available at www.healthtech.com/pcc/overview.aspx)            Register by June 27th and save up to $400!

PMF welcomes, Mr. Christopher Weeler from Far East Capital as our guest speaker to discuss business financing strategies for business working in US and China. A Case Study of PMF's Supply Chain Finance will present an example on how the right integration of financial product can strengthen your whole supply chain and lead to explosive and solid growth.  PMF will discuess its key products in the following areas: Trade Finance, Letters of Credit, Guarantees, Credit Insurance, and real-time support in via its China Offices for Sourcing, Logistics, QA Programs.                            (more info and registration available at http://www.pmfbancorp.com/register.asp)

Fees: $50 per person unless member participating partner

Mr. Stephen Perl, CEO of Guangdong Baolida Commerce and 1st PMF Bancorp (USA) will speak on current sales and distribution channels in China. Mr. Perl will provide Case Studies on a variety of products in a package presented to all attendees. The Case Studies will discuss Sporting Goods and Cosmetics product sales/distribution channels for Major U.S. and Chinese Brands.
(more info on event available at http://www.pmfbancorp.com/register.asp)

Fees: $40
Breakfast an Parking will be provided.